Protalix BioTherapeutics, Inc. Share Price
PLXProtalix BioTherapeutics, Inc. Stock Performance
Open $2.90 | Prev. Close $2.96 | Circuit Range N/A |
Day Range $2.90 - $3.02 | Year Range $1.32 - $3.10 | Volume 1,23,474 |
Average Traded $2.97 |
Protalix BioTherapeutics, Inc. Share Price Chart
About Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. It operates in the United States, Australia, Canada, Israel, Brazil, Russia, and Turkey. The company is headquartered in Hackensack. New Jersey.
Protalix BioTherapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Feb-26 | $2.76 | $2.90 | +5.66% |
03-Feb-26 | $2.69 | $2.74 | +4.98% |
02-Feb-26 | $2.35 | $2.61 | +12.50% |
30-Jan-26 | $2.09 | $2.32 | +11.54% |
29-Jan-26 | $2.06 | $2.08 | +1.46% |
28-Jan-26 | $2.10 | $2.05 | -3.30% |
27-Jan-26 | $2.10 | $2.12 | +3.41% |
FAQs on Protalix BioTherapeutics, Inc. Share Price
Can I buy Protalix BioTherapeutics, Inc. shares in India?
What is the share price of Protalix BioTherapeutics, Inc.?
What is the 5 year returns of Protalix BioTherapeutics, Inc.?
What are the high & low stock price of Protalix BioTherapeutics, Inc. today?
What is the 52-week high and low of Protalix BioTherapeutics, Inc. stock?